These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
670 related articles for article (PubMed ID: 19305027)
21. Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens. Gutierrez-Delgado F; Maloney DG; Press OW; Golden J; Holmberg LA; Maziarz RT; Hooper H; Buckner CD; Appelbaum FR; Bensinger WI Bone Marrow Transplant; 2001 Sep; 28(5):455-61. PubMed ID: 11593318 [TBL] [Abstract][Full Text] [Related]
22. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation. Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544 [TBL] [Abstract][Full Text] [Related]
23. Long-term thyroid disorders in pediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning. Cima LN; Martin SC; Lambrescu IM; Stejereanu L; Zaharia C; Colita A; Fica S J Pediatr Endocrinol Metab; 2018 Aug; 31(8):869-878. PubMed ID: 29935114 [TBL] [Abstract][Full Text] [Related]
24. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center. Huang X; Liu D Clin Transpl; 2011; ():237-45. PubMed ID: 22755417 [TBL] [Abstract][Full Text] [Related]
25. Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma. Hänel M; Kröger N; Sonnenberg S; Bornhäuser M; Krüger W; Kroschinsky F; Hänel A; Metzner B; Birkmann J; Schmid B; Hoffknecht MM; Fiedler F; Ehninger G; Zander AR Ann Hematol; 2002 Feb; 81(2):96-102. PubMed ID: 11907790 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays. Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932 [TBL] [Abstract][Full Text] [Related]
27. [Results of treatment of children with chronic myelogenous leukaemia (CML) obtained by the Polish Paediatric Leukaemia/Lymphoma Study Group]. Chybicka A; Kałwak K; Bogusławska-Jaworska J; Turkiewicz D; Armata J; Balcerska A; Bubała H; Boruczkowski D; Cwiklińska M; Hicke A; Kaczmarek-Kanold M; Kolecki P; Kowalczyk J; Krauze A; Matysiak M; Płoszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sikorska-Fic B; Staszak-Kowalska R; Tomaszewska R; Wiśniewska-Slusarz H; Wachowiak J; Wysocki M; Med Wieku Rozwoj; 2000; 4(1 Suppl 2):49-55. PubMed ID: 12021462 [TBL] [Abstract][Full Text] [Related]
28. [A comparison of the therapeutic effects between related donor and unrelated donor allogeneic hematopoietic stem cell transplantation in treatment of leukemia]. Yang K; Liu QF; Fan ZP; Sun J; Xu D; Wei YQ; Zhang Y; Meng FY Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):135-9. PubMed ID: 17445441 [TBL] [Abstract][Full Text] [Related]
29. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia]. Wang Y; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Shi HX; Zhang YC; Wang JZ; Zhang XU; Chen Y; Huang XJ; Lu DP Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271 [TBL] [Abstract][Full Text] [Related]
31. [HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases]. He Y; Feng SZ; Wang M; Wei JL; Qin TJ; Zhou Z; Zhai WJ; Qiu LG; Han MZ Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):389-92. PubMed ID: 16251016 [TBL] [Abstract][Full Text] [Related]
32. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency. Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864 [TBL] [Abstract][Full Text] [Related]
33. Primary distal femur T-cell lymphoma after allogeneic haematopoietic stem cell transplantation for chronic myeloid leukaemia: a rare case report and literature review. Han Q; Sun M; Wu L; Chen J; Wang W; Liu C; Chen H; Du G J Int Med Res; 2014 Apr; 42(2):598-605. PubMed ID: 24501166 [TBL] [Abstract][Full Text] [Related]
34. [Effects of allogeneic hematopoietic stem cell transplantation on 60 patients with myelodysplastic syndrome]. Lu Y; Wu T; Cao XY; Wang JB; Yin YM; Lu DP Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):200-3. PubMed ID: 20450649 [TBL] [Abstract][Full Text] [Related]
35. TBI/Cy followed by auto-HSCT is a good choice next to allo-HSCT for patients with T-LBL/ALL. Mao J; Ge J; Ding S; Sun Z; Nan F; Yu H; Ding J; Wang X; Liu Z; Zhang M; Fu X Sci Rep; 2024 Sep; 14(1):22356. PubMed ID: 39333693 [TBL] [Abstract][Full Text] [Related]
36. [A comparison of toxicity and efficacy between busulfan plus fludarabine and busulfan plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia]. Liu H; Fan ZP; Jiang QL; Huang F; Zhou HS; Zhang X; Yu GP; Wu MQ; Sun J; Liu QF Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):880-4. PubMed ID: 23291027 [TBL] [Abstract][Full Text] [Related]
37. Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma. Ingram W; Devereux S; Das-Gupta EP; Russell NH; Haynes AP; Byrne JL; Shaw BE; McMillan A; Gonzalez J; Ho A; Mufti GJ; Pagliuca A Br J Haematol; 2008 Apr; 141(2):235-43. PubMed ID: 18318762 [TBL] [Abstract][Full Text] [Related]
38. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia. Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460 [TBL] [Abstract][Full Text] [Related]
39. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [TBL] [Abstract][Full Text] [Related]
40. [Impact of HLA compatibility on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia]. ZHANG Y; CHEN YK; FAN ZP; XU D; JIANG QL; SUN J; LIU QF Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):438-42. PubMed ID: 21421478 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]